American Strategic Investment Co. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data American Strategic Investment Co. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	47.6	58.4	62.4				0.8	0.7	0
General and administrative	4.93	8.09	8.96	6.35	7.57	8.7	12.5	9.38	9.22	8.27
Operating expenses	60.3	70.5	73.7	76.1
Operating income	-12.7	-12.1	-11.3	-5.58	-22.6	-20.4	-26.9	-87.1	-121	4.4
Interest expense	7.4	11.2	13.3	17.2	19.1	19.1	18.9	18.9	19.5	15.3
Interest income	0.34	0.25	0.44	0.85	0.79	0.05
Other non-operating income	-7.06	-11	-12.9	-16.3	-18.4	-19	-19	-18.8	-19.4	-25.6
Pre-tax income				-21.9	-41	-39.4	-45.9	-106	-141	-21.2
Income tax				0	0	0.04	0	0	0	0
Net income	-19.8	-23.1	-24.1	-21.9	-41	-39.5	-45.9	-106	-141	-21.2
EBITDA	12.9	17.4	18.4	25.6	9.14	10.7	1.72	-60.6	-103	17.2
EPS, basic	-12.50	-14.45	-15.03	-13.75	-25.67	-24.42	-26.59	-47.57	-56.51	-8.32
EPS, diluted	-12.50	-14.45	-15.03	-13.75	-25.67	-24.42	-26.59	-47.57	-56.51	-8.32
Shares, basic (weighted)	1.57	1.59	1.61	1.59	1.6	1.62	1.73	2.23	2.49	2.55
Shares, diluted (weighted)	1.57	1.59	1.61	1.59	1.6	1.62	1.73	2.23	2.49	2.55
Dividend per share	29.48	29.48	4.80	3.20	0.39	3.20	1.60

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	47.7	39.6	48	51.2	31	11.7	9.22	5.29	9.78	1.3
Lease right-of-use assets			0	55.6	55.4	55.2	55	54.7	54.5	0
Intangible assets	91.2	77	66.5	61.5	50.9	42.2	35.3	30.2	5.88	4.06
Total assets	774	760	774	901	862	823	790	694	507	445
Total liabilities	233	279	330	481	480	472	469	469	421	380
Paid-in capital	680	692	686	686	687	691	699	730	731	732
Retained earnings	-141	-211	-242	-264	-306	-351	-399	-505	-646	-667
Other comprehensive income	0.01	0	0	-1.33	-3.4	-1.55	1.64	0.41	0	0
Shareholders' equity	540	481	444	421	378	339	301	225	85.6	64.8
Minority interests				0	4.01	12.1	20.5	0
Total equity	540	481	444	421	382	351	322	225	85.6	64.8
Total liabilities and equity	774	760	774	901	862	823	790	694	507	445
Shares outstanding	1.58	1.61	3.88	1.6	12.8	1.66	1.89	2.33	2.63	2.69

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-19.8	-23.1	-24.1	-21.9	-41	-39.5	-45.9	-106	-141	-21.2
Depreciation and amortization	25.6	29.5	29.7	31.2	31.7	31.1	28.7	26.5	18.4	12.8
Stock-based compensation	0.06	0.07	0.02	0.09	3.87	8.48	8.78	5.86	0.41	0.36
Deferred income tax										-6.6
Change in payables	2.8	3.27	-0.75	-2.15	-0.55	-0.11	3.94	0.87	2.37	15.6
Cash from operations	4.13	2.28	-7.08	-1.6	-13.6	-7.92	-0.49	-7.41	-4	-7.75
Capital expenditures	-16.7	-10.8	-8.99	-7.71	-3.76	-3.38	-5.56	-4.06	-1.29	-0.76
Sales and maturities of investments	0	0.49	0	0
Cash from investing	-95.9	-10.3	-14.9	-46	-3.76	-3.38	-5.56	0.07	59.9	-3.79
Stock issued	0	0		0	0	5.27	0	0
Share buybacks	-12.5	-7.34	-10.3	0	0	-0.18	0	0	-0.23	0
Dividends paid	-25.3	-28.3	-7.48	0	-0.62	-5.2	-2.67	0	0
Cash from financing	-41.1	5.45	29.6	51.1	-0.97	-0.28	-6.27	4.03	-49.7	0.65
Net change in cash	-133	-2.61	7.59	3.5	-18.3	-11.6	-12.3	-3.31	6.13	-10.9
Free cash flow	-12.6	-8.55	-16.1	-9.31	-17.3	-11.3	-6.04	-11.5	-5.29	-8.51
Interest paid	4.62	9.66	12.3	15.5	16.7	17.6	17.4	17.3	18.5	11.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $6.33 on September 28, 2026.

Profitability

Metric	Value	How it is calculated
Return on equity (ROE)	24.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.9%	Net income / average total assets.
Return on invested capital (ROIC)	61.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.

Growth

Metric	Value	How it is calculated
EBITDA CAGR, 3y	115.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	13.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-24.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-40.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-29.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-12.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-17.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-12.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	2.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	13.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	9.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Liabilities / assets	88.1%	Total liabilities / total assets.
Interest coverage	2.41x	Operating income / interest expense.
Tangible book value	$52.9M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
FCF conversion	-21.1%	Free cash flow / net income, when net income is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$4.75	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
FCF per share	-$1.00	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$0.75	Cash from operations / diluted weighted shares.
Book value per share	$16.72	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$16.72	Tangible book value / shares outstanding.
Cash per share	$0.77	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$20.0M	Share price x shares outstanding.
Enterprise value	$17.6M	Market cap + total debt - cash - short-term investments.
P/E	1.54x	Market cap / net income. Only when net income is positive.
P/B	0.38x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.38x	Market cap / tangible book value, when positive.
EV/EBIT	0.45x	Enterprise value / operating income, when both are positive.
EV/EBITDA	0.35x	Enterprise value / EBITDA, when both are positive.
FCF yield	-13.7%	Free cash flow / market cap.
Earnings yield	64.8%	Net income / market cap (the inverse of P/E).

Was American Strategic Investment Co. profitable in fiscal 2025?

No. It reported a net loss of $21.2M.

How much free cash flow did American Strategic Investment Co. generate in fiscal 2025?

Cash from operations of $7.8M minus capital expenditures of $757.0K left free cash flow of -$8.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to American Strategic Investment Co.